Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2017 | The role of pharmacists in utilizing novel pancreatic cancer treatments

Islam Elkonaissi • 6 Oct 2017
BOPA 2017
Pancreatic Cancer

Speaking from the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK, Islam Elkonaissi of The Royal Marsden NHS Foundation Trust, London, UK, discusses how pharmacists play an important role in the introduction and effective utilization of new drugs for pancreatic cancer. Mr Elkonaissi highlights how meetings such as BOPA aid in this process.

More from Islam Elkonaissi

2:30
Bringing oncology pharmacists together: 10 years forward
Islam Elkonaissi • 10 Oct 2019
4:48
Minimizing the risk of steroid-induced hyperglycemia in NSCLC patients receiving immunotherapy
Islam Elkonaissi • 10 Oct 2019
1:55
Clinical update: lung and pancreatic cancer
Islam Elkonaissi • 6 Oct 2017
1:58
Multidisciplinary cancer research: overcoming the odds
Islam Elkonaissi • 6 Oct 2017

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:16
Entinostat with nivolumab in pancreatic ductal adenocarcinoma
Marina Baretti • 9 Apr 2024
0:40
The limited therapeutic efficacy of checkpoint inhibitors for pancreatic cancer
Olatunji Alese • 8 Apr 2024
0:48
Siltuximab and spartalizumab in advanced pancreatic adenocarcinoma
Olatunji Alese • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals